Sorafenib response in hepatocellular carcinoma: MicroRNAs as tuning forks

E-ISSN： 1872-034x|48|1|5-14

ISSN： 1386-6346

Source： HEPATOLOGY RESEARCH, Vol.48, Iss.1, 2018-01, pp. : 5-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MicroRNA‐425‐3p predicts response to sorafenib therapy in patients with hepatocellular carcinoma

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 3, 2015-03 ,pp. : 1077-1086

John Wiley & Sons Inc

Access to resources Recommend Favorite

Targeting c‐Met in Cancer by MicroRNAs: Potential Therapeutic Applications in Hepatocellular Carcinoma

DRUG DEVELOPMENT RESEARCH, Vol. 76, Iss. 7, 2015-11 ,pp. : 357-367

John Wiley & Sons Inc

Access to resources Recommend Favorite

Identification of microRNAs specific for epithelial cell adhesion molecule–positive tumor cells in hepatocellular carcinoma

HEPATOLOGY, Vol. 62, Iss. 3, 2015-09 ,pp. : 829-840

John Wiley & Sons Inc

Access to resources Recommend Favorite

Circulating microRNAs in exercise

SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS, Vol. 25, Iss. 2, 2015-04 ,pp. : e149-e154

John Wiley & Sons Inc

Access to resources Recommend Favorite

Early evaluation of response to sorafenib for hepatocellular carcinoma by duplex Doppler ultrasonography

HEPATOLOGY RESEARCH, Vol. 45, Iss. 9, 2015-09 ,pp. : 976-985

John Wiley & Sons Inc

Access to resources Recommend Favorite